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In a recent editorial, J0rgen Slots and Thomas Pallasch have
commented on the dentist's role in halting the
development of antimicrobial resistance among bacterial
species. The spread of antimicrobial-resistant micro-organisms
among human and animal hosts has been the subject of much
concern among physicians and discussion in the scientific and
lay literature (Garrett, 1994). It is very appropriate that this
issue be addressed from a dental perspective.
Slots and Pallasch have carefully reviewed the current
usage of systemic antimicrobials in dental practice and
describe two situations where systemic antimicrobials
would be used for treatment purposes, and two situations in
which a prophylactic usage would seem to be
recommended. The treatment indications apply to the
treatment of acute orofacial infections with systemic
manifestations, and to the treatment of certain types of
severe periodontitis and peri-implantitis. The prophylactic
indications would apply to medical conditions such as
endocarditis and for the "prevention of traumatic/infectious
sequelae to surgical dental procedures". They then qualify
these prophylactic situations to eliminate any ambiguities.
For example, they provide a comprehensive listing of
medical conditions for which antimicrobial prophylactics
would and would not be recommended during dental
treatment. They review those dental surgical procedures
where prophylactic antibiotics might be indicated, and
conclude that "the only dental treatment that might qualify
would be the placement of dental implants".
The usage of systemic antimicrobials for prophylactic
purposes in dentistry is rarely based upon documented
clinical data. Even in the well-accepted usage of
prophylactic antimicrobials in individuals with endocarditis,
the estimated rate of protection from an infectious episode is
balanced by the estimated rate of death from an untoward
reaction to the systemic antimicrobial. Yet, for mainly legal
and historical purposes, this practice has become the de facto
standard of care.
There is even less support for the routine use of systemic
antimicrobials prophylactically following oral and/or
periodontal surgery. The prevalence of post-operative
infections following periodontal surgery is less than one
percent, and this low risk would not justify the prophylactic
usage of systemic antimicrobials. Yet according to American
Academy of Periodontology surveys conducted in 1981 and
1987, about two-thirds of the respondents reported using
mainly tetracyclines and penicillins for just this purpose.
This usage would seem unwarranted and is contrary to the
recommendation of the Medical Letter that antibiotic
prophylaxis should be used only for surgical procedures
with a high infection rate.
Generally speaking, the dentist has not overused or
misused antibiotics in treatment situations. This has a
historical basis, since the prevailing 19th century treatment
paradigm was based on the assumption that dental decay
and periodontal disease were due to this non-specific
overgrowth of plaque bacteria, i.e., the "non-specific plaque"
hypothesis. This paradigm essentially dismissed any
suggestion of the use of chemical antimicrobial agents,
because they were unsafe and unnecessary, given the
alternative of physical debridement of the tooth by
mechanical means. In that context, the non-use or minimal
usage of systemic antimicrobials was appropriate and helped
keep the dentist from the abusive usage of antimicrobials.
But as we enter the 21st century, a new treatment
paradigm has appeared which indicates that both dental
decay and periodontal disease are specific, albeit chronic,
bacterial infections. Support for the specific-plaque
hypothesis rests upon epidemiological evidence that while
decay and periodontal disease are ubiquitous in the
population, the severe forms are clustered in small subsets
of individuals. When plaques from these individuals are
examined bacteriologically, plaques from diseased sites or
from patients with high dental morbidities have elevated
levels and/or proportions of certain bacterial species when
compared with plaques taken from non-diseased tooth sites
or from dentally healthy individuals.
The unequivocal demonstration of an etiologic role for
specific organisms in chronic mucous membrane infections
is fraught with difficulties. This is even more so when the
putative odontopathogens - such as Streptococcus mutans,
Lactobacilli casei, Treponema denticola, Bacteroides forsythus,
Porphyromonas gingivalis, and Prevotella intermedia, among
others - are commonly found in plaque and saliva samples
of dentally healthy individuals. Because dental decay and
periodontal disease behave as endogenous infections, this
rules out any diagnostic significance associated with the
mere presence of these organisms. It is necessary to
demonstrate elevated levels and proportions of these species
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before any diagnostic implications can be made from
bacteriological testing. Such quantitative bacteriological
tests are not readily available, and those that exist are both
underutilized and minimally documented. This is of
immediate concern, because if antimicrobials are to be used
in dental therapies, they will need to be focused toward the
suppression or elimination of specific bacterial species in the
disease-associated plaques.
Once the concept of infection is introduced for dental
decay and periodontal disease, then the assumption is that
all reasonable means to treat these infections, including the
prescription usage of systemic antimicrobials, will be
considered. This is a departure from traditional dental
therapy and comes at a time when most health authorities
are urging caution in the usage of systemic antimicrobials. If
there will be a testing ground for the relative merits of the
antimicrobial approach to treatment vs. the traditional
surgical-debridement approach to treatment, it will be in
periodontal therapy.
The success of agents such as metronidazole, clindamycin,
and doxycycline in refractory periodontitis begs the question
as to how successful these agents would be if introduced
earlier in the treatment process, prior to any surgical
intervention. There is general agreement that the surgical
approach is successful in about 80% of advanced cases but,
because of its cost and general unpleasantness, is not well-
accepted by the public. More people are retaining their teeth
into old age and therefore will be at risk to developing
periodontal disease. Because of this, and because periodontal
disease is being suggested as a risk factor for coronary heart
disease and stroke, there is a need to reconsider how we treat
advanced forms of periodontal disease.
We have conducted three double-blind clinical studies in
which systemic metronidazole in conjunction with mechanical
debridement (scaling and root planing) was shown to reduce
the need for access surgery. We selected patients in whom
access surgery and extractions were deemed necessary
according to traditional criteria. We then showed that in over
90% of these patients, an anaerobic infection - defined as a
predominance of anaerobic bacteria such as spirochetes, T.
denticola, P. gingivalis, and B. forsythus - was present in four
plaque samples removed from sites with deep pocketing and
bone loss. The combination of clinical disease plus the
demonstration of anaerobes led us to choose metronidazole,
an antimicrobial agent that is specific for Gram-negative
anaerobes. We used rigorous debridement to reduce the
bacterial loads on the tooth surface non-specifically, and then
followed with a dosage of metronidazole, adjusted for the
patient's body weight, for a one- or two-week period. Because
compliance with metronidazole may not be good, we
evaluated doxycycline and found this agent also to be effective
in reducing surgical needs.
In each of these studies, the combination of debridement
plus one or two weeks of unsupervised usage of systemic
metronidazole reduced the need for surgery, compared with
the debridement plus placebo control. In the third study, we
were able to show that by the administration of up to five
rounds of either systemic or locally delivered antimicrobials,
about 90%o of the teeth initially scheduled for surgery, or in
some cases extractions, could be spared from surgery or
extractions. Only 20% of the patients required some form of
surgery, and then at a reduced level. This is comparable
with the 20% of patients who are refractory to traditional
therapy and need systemic antimicrobials.
These results suggest that patients and clinicians now
have a choice in the treatment of advanced forms of
periodontal disease: the traditional surgical approach with
systemic antimicrobials held in reserve for refractory cases,
or the infection approach with surgery held in reserve for
refractory cases (teeth). In both treatment approaches, the
need for the diagnosis of infection and the choice of
antimicrobial agent is important. This is a point emphasized
by Slots and Pallasch and cannot be ignored.
As promising as these results appear, there is a concern
that that they could be trivialized by the thinking that
antimicrobials are a panacea for all forms of periodontal
disease, and possibly could be used prophylactically to
prevent individuals from getting periodontal disease.
Antimicrobials are powerful agents when used in well-
focused ways. We carefully selected patients who had
advanced forms of periodontitis, and in whom access
surgery would be indicated according to prevailing
treatment practices. Because we were able to document an
anaerobic infection, we were able to select the appropriate
agent. This approach and results cannot be directly
transferred to forms of moderate periodontitis or to
gingivitis. These clinical entities respond to mechanical
debridement, and both risk-benefit and cost-benefit
considerations would not seem adequate to justify the usage
of antimicrobial agents.
We are at a point in dentistry where clinical dividends can
be achieved from the many years of research which have
shown that most forms of dental decay and periodontal
disease are diagnosable and treatable infections. We are also
in a transition process from a health profession which relied
exclusively upon a surgical approach to combat the ravages
of dental decay and tooth loss, to one in which a combined
surgical and medical approach will be needed to maintain an
individual's optimal dental health for a lifetime. We will need
to recognize those individuals at risk to clinical infections and
to be able to treat them cautiously. The alarms being raised
about the overuse and misuse of systemic antimicrobials need
to be heeded so that we do not as a profession contribute to
this "coming plague". We will need to add the knowledge of
an infectious disease specialist to our surgical skills.
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